Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks — Thanomsak Anekthananon (2012) | RDL Network
Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
Journal of Antimicrobial Chemotherapy 68(3): 697-707
Article 2012 English
Authors
TA
Thanomsak Anekthananon
SP
S. Pukritayakamee
WR
Winai Ratanasuwan
Abstract
1 min read
ObjectivesLong-term chemoprophylaxis using neuraminidase inhibitors may be needed during influenza epidemics but safety data are limited to several weeks. We sought to assess the tolerability of oseltamivir and zanamivir as primary prophylaxis over 16 weeks.
T. Anekthananon, S. Pukrittayakamee, W. Ratanasuwan, P. Jittamala, P. Werarak, P. Charunwatthana, S. Suwanagool, Saranath Lawpoolsri, K. Stepniewska, P. Sapchookul, P. Puthavathana, Claudio Tadashi Fukuda, N. Lindegardh, Joel Tärning, Sir Nicholas White, N. Day, Walter Taylor
Leopoldo Villegas, Rose McGready, Mg Htway, Moo Kho Paw, Mupawjay Pimanpanarak, Ratree Arunjerdja, Samuel Jacher Viladpai‐nguen, Brian Greenwood, Sir Nicholas White, François Nosten
Eduard Vieta, Núria Cruz, Javier García‐Campayo, Rosario de Arce, José Manuel Crespo, Vicenç Vallès, Josefina Pérez‐Blanco, Ernesto Roca, J.M. Olivares, Ángel Moríñigo, Raul Fernández-Villamor, Mercé Comes
Discussion(0)
No comments yet. Be the first to comment.